Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RIGL | PROF | ACRV | ||
| Company | Rigel Pharmaceuticals | Profound Medical Corp | Acrivon Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.1300 | 7.73 | 8.22 | ||
| High | 1.1500 | 8.15 | 10.16 | ||
| Low | 1.0600 | 7.49 | 8.18 | ||
| Last | 1.0700 | 7.70 | 10.00 | ||
| Change | -0.0300 | -0.33 | +1.54 | ||
| % Change | -2.73% | -4.11% | +18.20% | ||
| Volume | 2,121,300 | 67,000 | 239,500 | ||
| 20-Day Average Volume | 1,928,055 | 25,390 | 2,221,235 | ||
| Previous Close | 1.1000 | 8.03 | 8.46 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.1797 | 8.00 | 8.84 | ||
| 20-Day Raw Stochastic | 17.14% | 28.99% | 69.35% | ||
| 20-Day Relative Strength | 36.48% | 42.56% | 61.07% | ||
| Weighted Alpha | -16.98 | -42.77 | -36.97 | ||
| Today's Opinion | 40% Sell | 100% Sell | 72% Buy | ||
| Previous Opinion | 24% Sell | 96% Sell | 56% Buy | ||
| Last Month's Opinion | 100% Buy | 64% Sell | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.31% since 04/22/24 | -0.77% since 04/22/24 | +5.15% since 04/22/24 | ||
| Low | 1.0600 on 04/29/24 | 7.49 on 04/29/24 | 7.80 on 04/25/24 | ||
| High | 1.1700 on 04/23/24 | 8.39 on 04/25/24 | 10.27 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | -27.70% since 03/28/24 | -9.73% since 03/28/24 | +39.86% since 03/28/24 | ||
| Low | 1.0100 on 04/19/24 | 7.30 on 04/19/24 | 5.70 on 04/08/24 | ||
| High | 1.4450 on 04/01/24 | 8.68 on 04/03/24 | 11.90 on 04/09/24 | ||
| 3-Month | |||||
| %Chg | -17.69% since 01/29/24 | -18.60% since 01/29/24 | +159.74% since 01/29/24 | ||
| Low | 1.0100 on 04/19/24 | 7.30 on 04/19/24 | 3.19 on 02/13/24 | ||
| High | 1.7300 on 03/06/24 | 9.55 on 01/30/24 | 11.90 on 04/09/24 | ||
| 6-Month | |||||
| %Chg | +46.54% since 10/27/23 | -6.55% since 10/27/23 | +99.20% since 10/27/23 | ||
| Low | 0.7275 on 10/30/23 | 7.11 on 01/05/24 | 3.19 on 02/13/24 | ||
| High | 1.7300 on 03/06/24 | 11.69 on 11/20/23 | 11.90 on 04/09/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 192,945 | 196,165 | 191,509 | ||
| Shares Outstanding, K | 175,405 | 24,429 | 22,637 | ||
| Annual Sales | 116,880,000 | 7,200,000 | 0 | ||
| Annual Net Income | -25,090,000 | -28,570,000 | -60,390,000 | ||
| Last Quarter Sales | 35,790,000 | 2,010,000 | 0 | ||
| Last Quarter Net Income | 740,000 | -8,910,000 | -19,250,000 | ||
| 60-Month Beta | 0.95 | 0.80 | 1.94 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 03/05/24 | -0.42 on 03/07/24 | -0.86 on 03/28/24 | ||
| Latest Earnings Date | 05/07/24 | 05/09/24 | 05/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||